American Journal of Medical and Biological Research
ISSN (Print): 2328-4080 ISSN (Online): 2328-4099 Website: Editor-in-chief: Apply for this position
Open Access
Journal Browser
American Journal of Medical and Biological Research. 2019, 7(1), 6-11
DOI: 10.12691/ajmbr-7-1-2
Open AccessArticle

Regulatory Activity of Ethanol Leaves Extract of Moringa Oleifera on Benzene Induced Leukemia in Wister Rat Using TNF-α Analysis

Phillip Abutu1, Oyewumi Amuda2, Oluwatobiloba Osinaya3 and Bemjamin Babatunde4,

1Medical Laboratory, Paelon Memorial Hospital, Lagos, Nigeria

2Microbiology, Nigerian Institute of Medical Research, Lagos, Nigeria

3Chemical Pathology, LAUTECH Teaching Hospital, Osogbo, Nigeria

4Haematology, Clina Lancet Laboratories, Lagos, Nigeria

Pub. Date: September 16, 2019

Cite this paper:
Phillip Abutu, Oyewumi Amuda, Oluwatobiloba Osinaya and Bemjamin Babatunde. Regulatory Activity of Ethanol Leaves Extract of Moringa Oleifera on Benzene Induced Leukemia in Wister Rat Using TNF-α Analysis. American Journal of Medical and Biological Research. 2019; 7(1):6-11. doi: 10.12691/ajmbr-7-1-2


Medicinal plants are important elements of indigenous medicinal system that have persisted in developing countries. Compounds that are capable of interacting with the immune system to up regulate or down regulate specific aspects of the host can be classified as immunomodulators. This study aimed at determining the regulatory activity of ethanol extract of Moringa oleifera in leukemic wistar rats using Tumuor necrosis factor assay. Thirty adult wistar rats were divided into three groups each containing ten wistar rats. Intravenous injection of 0.2 mg/ml of benzene chromosolv was administered 48 hourly for four weeks. 0.2 ml of 100 mg/ml of ethanol extract of Moringa oleifera was administered orally pre, during and post leukemia induction. Group A (Normal rats), Group B (benzene administration only) and Group C (benzene + ethanol Moringa oleifera extract). After a total period of eight weeks, the plasma samples of each of the groups was collected and analyzed using TNF-α kit by ELISA technique. The result showed that there was no significant difference in TNF-α levels between all the groups. However there was a mean ± standard deviation difference between the groups; the group of rats induced with leukemia without treatment (leukemia control) with 229.38 ± 58.17 ng/L, those treated with EMO after induction of leukemia had a mean and standard deviation of 219.38 ± 18.52 ng/L while the normal control group 209.04 ± 17.51 ng/L. This study concluded that the anti-cancer properties of Ethanol extract of Moringa oleifera results in the down regulation of TNF-α as treatment of cancer occurs. Also TNF-α level may be indicative of the clinical efficacy of therapy.

moringa oleifera wistar rats TNF-α ELISA ethanol extract benzene chromosolv

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  Shomon, M. J. (2002). Living well with autoimmune disease.
[2]  Hayday, A., Girardi, M., Tigelaar, B. Julie L. Woodward, M. Jessica, S., and Susaanah, B. (2008). Cancer immunology and immunotherapy. King’s college school of medicine at Guy’s Hospital.
[3]  Cancer research institute. (2009).
[4]  Ohtani, H., Dunn, I.F. and Cuvy, W.T. (2007). Focus on TILS: prognostic significance of Tumour infilterating lymphoctes in human glioma”. cancer immunity. 7: 4.
[5]  Yee, C., Thompson J. A. and Byrd, D. (2002). Adoptive T cell therapy using antigen-specific CD 8 t T-cell clones for the treatment of patients with metatastic melanoma: in vivo persistence, Migration and anti tumor effect of transferred T cells Proc Natl. Acad sci USA. 99: 16168-16173.
[6]  Beutler, B. and Cerami, A. (1988). Tumor necrosis, cachexia, shock, and inflammation: A common mediator. Annual Review of Biochemistry. 57:505-518.
[7]  National Toxicology Program. (2011). Report on carcinogens, 12th Edition Research triangle park N C: US department of health and human Services, public health series National toxicology program 499 pp.
[8]  Smith, M.T. (1996). The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. 104 (6): 1219-1225.
[9]  National research council. (2006). “Moringa” lost crops of Africa: volume II vegetables. Lost crops of Africa. National Academics Press. 309: 10333-6.
[10]  Gummert, J. F., Ikonen, T. and Morris, R. S. (2008). J am soc Nephrol. 10: 1366-1380.
[11]  Oubre, A.Y., Carlson, T.J. King, S.R. and Reaven, E.M. (1970). From plants to patient an ethanomedical approach to the identification of a new drug for the treatment of non-insulin dependent diabetes mellitus. Diabetologia. 40 (5): 614-617.
[12]  Calixto, J. B., Santos, A. R., Cechinal, V. and Yunes, R. A. (1998). A review of the plants genus phyllantaus, their Chemistry, Pharmacology, and Therapeutic potential. Med. Res. Rev. 84 (2): 274-278.
[13]  Morton, J.E. (1991). The horseradish tree, Moringa pterygosperma (Moringaceae)- a boon to arid lands. Economic Botany. 45(3): 318-333.
[14]  Fahey, J.W. (2005). Moringa oleifera: review of the medical evidence for its nutritional, therapeutic, and prophylactic properties part. Trees for life jounnal. 1(5): 1-13.
[15]  Kirtikar, K.R. and Basu, B.D. (1975). Indian medicinal plants (MLS Bisherg Singh, mahendral pal singh, new canaught place, dehra dun) 2nd Edition, Reprint. 1975, vol. pp 676-683.
[16]  Fuglie, L.G. (1999). The Miracle tree: moringa olefiera: Natural Nutrition for the tropics, church world service, darker, 68 pp, revised in and published as the miracle tree: the multiples attribute of moringa. 77pp.
[17]  Siddhuraju, P., Becker, K. (2003). Antioxidant properties of various solvent extracts of total phenolic constituents from three different agroclimatic origins of drumstick tree (Moringa oleifera Lam.) leaves. Journal of Agricultural and Food Chemistry. 51: 2144-2155.
[18]  Mayhajan, S.G. and Mahta, A.A. (2007). Protective effect of ethanol extract of Moringa olefera lams. Against inflammation associated with development of arthritis in rats. J immunotoxicol 4 (1): 39-47.
[19]  Abdulkareem, F. (2009). Epidemiology and incidence of common cancers in Nigeria.
[20]  Basu, S., Pathak, S.K. and Banerjee, A. (2007). Execution of macrophage apoptosis by PE_PGRS 33 of mycobacterium tuberculosis is mediated by toll-like receptor 2 dependent release of tumor necrosis factor. J Biol Chem. 282:1039-1050.
[21]  Lombardo, E., Alvarez-Barrientos, A., Maroto, B., Bosca, L. and Knaus, U.G. (2007). TLR4-mediated survival of macrophages is MyD88 dependent and requires TNF-_ autocrine signalling. J Immunol. 178: 3731-3739.
[22]  Pignone, M., Nicoll, D. and McPhee, S.J. (2004). Pocket guide to diagnostic test, New York: McGraw. Hill. 4:191.
[23]  Wibell, L., Evrin, P.E and Beggard, I. (1973). Serum beta-2 microglobulin in renal disease. Nephron. 10: 320-331.
[24]  Abrams, B., Duncan, D., and Hertz-Piccioto, I. (1993). A prospective study of dietary intake and acquired immune deficiency syndrome in HIV-sero-positive homosexual men. Journal of Acquired Immune Deficiency Syndrome. 8: 949-958.
[25]  Aggarwal, B.B., and Vilcek, J. (2002). Tumour necrosis Factor: structure, function & mechanism of action. Marcel Dekker Ine.
[26]  Asres, K. (1995). The major constituents of the acetone fraction of Ethiopian Moringa stenopetala leaves. Mansoura Journal of Pharmacological Science 11(1): 55-64.
[27]  Campos, L., Vu Van, H., Ville, D., Imbert, C., Gentilhomme, Y., Luo, C., Fiere, D. and Viala, J.J. (1984). Serum beta-2 microglobulin in adult myeloid acute leukemia. Annals of hematology. 48(4):221-226.